NEW YORK (GenomeWeb News) – GNS Healthcare today said that it will collaborate with contract research organization Covance on developing data-driven models to assist pharmaceutical firms in optimizing the efficiency and cost-effectiveness of drug development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.